Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
THYMVITAL
- Development stage
- Unknown
- Lead developer
- biosyn Arzneimittel
- Modality
- Small Molecules, Peptides
- Administration
- Oral
01
Overview
THYMVITAL is a dietary supplement developed and marketed by biosyn Arzneimittel GmbH, specifically formulated to support immune system function and provide antioxidant protection. It is a combination product containing thymus extract (derived from calf thymus), zinc (as zinc gluconate), and selenium (as sodium selenite pentahydrate). The product features a specialized enteric coating (galenic formulation) designed to protect the sensitive thymus peptides from degradation by gastric acid, ensuring their release and absorption in the small intestine. Zinc and selenium are included for their roles as essential cofactors that contribute to normal immune function and the protection of cells from oxidative stress. It is typically administered as a once-daily oral capsule.
- Brand names
- THYMVITAL
Beyond the preview
Go deeper on THYMVITAL.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on THYMVITAL.